Global Dermatology Drug Market Growth 2020-2025
According to this study, over the next five years the Dermatology Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermatology Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Dermatology Drug, covering the supply chain analysis, impact assessment to the Dermatology Drug market size growth rate in several scenarios, and the measures to be undertaken by Dermatology Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
External Use
Oral
Injection
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Psoriasis
Skin Infections
Acne
Dermatitis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie
LEO Pharma
Johnson & Johnson
Galderma
Bristol-Myers Squibb
Bayer
Merz Pharma
Novartis
Valeant
Pfizer
GlaxoSmithKline
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dermatology Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Dermatology Drug market by identifying its various subsegments.
Focuses on the key global Dermatology Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dermatology Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dermatology Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dermatology Drug Consumption 2015-2025
2.1.2 Dermatology Drug Consumption CAGR by Region
2.2 Dermatology Drug Segment by Type
2.2.1 External Use
2.2.2 Oral
2.2.3 Injection
2.3 Dermatology Drug Consumption by Type
2.3.1 Global Dermatology Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Dermatology Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Dermatology Drug Sale Price by Type (2015-2020)
2.4 Dermatology Drug Segment by Application
2.4.1 Psoriasis
2.4.2 Skin Infections
2.4.3 Acne
2.4.4 Dermatitis
2.4.5 Other
2.5 Dermatology Drug Consumption by Application
2.5.1 Global Dermatology Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Dermatology Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Dermatology Drug Sale Price by Type (2015-2020)
3 Global Dermatology Drug by Company
3.1 Global Dermatology Drug Sales Market Share by Company
3.1.1 Global Dermatology Drug Sales by Company (2018-2020)
3.1.2 Global Dermatology Drug Sales Market Share by Company (2018-2020)
3.2 Global Dermatology Drug Revenue Market Share by Company
3.2.1 Global Dermatology Drug Revenue by Company (2018-2020)
3.2.2 Global Dermatology Drug Revenue Market Share by Company (2018-2020)
3.3 Global Dermatology Drug Sale Price by Company
3.4 Global Dermatology Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Dermatology Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Dermatology Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dermatology Drug by Regions
4.1 Dermatology Drug by Regions
4.2 Americas Dermatology Drug Consumption Growth
4.3 APAC Dermatology Drug Consumption Growth
4.4 Europe Dermatology Drug Consumption Growth
4.5 Middle East & Africa Dermatology Drug Consumption Growth
5 Americas
5.1 Americas Dermatology Drug Consumption by Countries
5.1.1 Americas Dermatology Drug Consumption by Countries (2015-2020)
5.1.2 Americas Dermatology Drug Value by Countries (2015-2020)
5.2 Americas Dermatology Drug Consumption by Type
5.3 Americas Dermatology Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Dermatology Drug Consumption by Regions
6.1.1 APAC Dermatology Drug Consumption by Regions (2015-2020)
6.1.2 APAC Dermatology Drug Value by Regions (2015-2020)
6.2 APAC Dermatology Drug Consumption by Type
6.3 APAC Dermatology Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Dermatology Drug by Countries
7.1.1 Europe Dermatology Drug Consumption by Countries (2015-2020)
7.1.2 Europe Dermatology Drug Value by Countries (2015-2020)
7.2 Europe Dermatology Drug Consumption by Type
7.3 Europe Dermatology Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Dermatology Drug by Countries
8.1.1 Middle East & Africa Dermatology Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Dermatology Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Dermatology Drug Consumption by Type
8.3 Middle East & Africa Dermatology Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dermatology Drug Distributors
10.3 Dermatology Drug Customer
11 Global Dermatology Drug Market Forecast
11.1 Global Dermatology Drug Consumption Forecast (2021-2025)
11.2 Global Dermatology Drug Forecast by Regions
11.2.1 Global Dermatology Drug Forecast by Regions (2021-2025)
11.2.2 Global Dermatology Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Dermatology Drug Forecast by Type
11.8 Global Dermatology Drug Forecast by Application
12 Key Players Analysis
12.1 AbbVie
12.1.1 Company Information
12.1.2 Dermatology Drug Product Offered
12.1.3 AbbVie Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 LEO Pharma
12.2.1 Company Information
12.2.2 Dermatology Drug Product Offered
12.2.3 LEO Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 LEO Pharma Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Dermatology Drug Product Offered
12.3.3 Johnson & Johnson Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Galderma
12.4.1 Company Information
12.4.2 Dermatology Drug Product Offered
12.4.3 Galderma Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Galderma Latest Developments
12.5 Bristol-Myers Squibb
12.5.1 Company Information
12.5.2 Dermatology Drug Product Offered
12.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bristol-Myers Squibb Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Dermatology Drug Product Offered
12.6.3 Bayer Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Merz Pharma
12.7.1 Company Information
12.7.2 Dermatology Drug Product Offered
12.7.3 Merz Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merz Pharma Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Dermatology Drug Product Offered
12.8.3 Novartis Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Valeant
12.9.1 Company Information
12.9.2 Dermatology Drug Product Offered
12.9.3 Valeant Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Valeant Latest Developments
12.10 Pfizer
12.10.1 Company Information
12.10.2 Dermatology Drug Product Offered
12.10.3 Pfizer Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer Latest Developments
12.11 GlaxoSmithKline
12.11.1 Company Information
12.11.2 Dermatology Drug Product Offered
12.11.3 GlaxoSmithKline Dermatology Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GlaxoSmithKline Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Dermatology Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of External Use
Table 5. Major Players of Oral
Table 6. Major Players of Injection
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Dermatology Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Dermatology Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Dermatology Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Dermatology Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Dermatology Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Dermatology Drug Value by Application (2015-2020)
Table 15. Global Dermatology Drug Value Market Share by Application (2015-2020)
Table 16. Global Dermatology Drug Sale Price by Application (2015-2020)
Table 17. Global Dermatology Drug Sales by Company (2017-2019) (K Units)
Table 18. Global Dermatology Drug Sales Market Share by Company (2017-2019)
Table 19. Global Dermatology Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Dermatology Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Dermatology Drug Sale Price by Company (2017-2019)
Table 22. Global Dermatology Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Dermatology Drug Products Offered
Table 24. Dermatology Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Dermatology Drug Consumption by Regions 2015-2020 (K Units)
Table 26. Global Dermatology Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Dermatology Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Dermatology Drug Value Market Share by Regions 2015-2020
Table 29. Americas Dermatology Drug Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Dermatology Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Dermatology Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Dermatology Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Dermatology Drug Consumption by Type (2015-2020) (K Units)
Table 34. Americas Dermatology Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Dermatology Drug Consumption by Application (2015-2020) (K Units)
Table 36. Americas Dermatology Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Dermatology Drug Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Dermatology Drug Consumption Market Share by Countries (2015-2020)
Table 39. APAC Dermatology Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Dermatology Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Dermatology Drug Consumption by Type (2015-2020) (K Units)
Table 42. APAC Dermatology Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Dermatology Drug Consumption by Application (2015-2020) (K Units)
Table 44. APAC Dermatology Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Dermatology Drug Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Dermatology Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Dermatology Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Dermatology Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Dermatology Drug Consumption by Type (2015-2020) (K Units)
Table 50. Europe Dermatology Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Dermatology Drug Consumption by Application (2015-2020) (K Units)
Table 52. Europe Dermatology Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Dermatology Drug Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Dermatology Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Dermatology Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Dermatology Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Dermatology Drug Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Dermatology Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Dermatology Drug Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Dermatology Drug Consumption Market Share by Application (2015-2020)
Table 61. Dermatology Drug Distributors List
Table 62. Dermatology Drug Customer List
Table 63. Global Dermatology Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Dermatology Drug Consumption Market Forecast by Regions
Table 65. Global Dermatology Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Dermatology Drug Value Market Share Forecast by Regions
Table 67. Global Dermatology Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Dermatology Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Dermatology Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Dermatology Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Dermatology Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Dermatology Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Dermatology Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Dermatology Drug Value Market Share Forecast by Application (2021-2025)
Table 75. AbbVie Product Offered
Table 76. AbbVie Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. AbbVie Main Business
Table 78. AbbVie Latest Developments
Table 79. AbbVie Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. LEO Pharma Product Offered
Table 81. LEO Pharma Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. LEO Pharma Main Business
Table 83. LEO Pharma Latest Developments
Table 84. LEO Pharma Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Product Offered
Table 86. Johnson & Johnson Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Galderma Product Offered
Table 91. Galderma Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Galderma Main Business
Table 93. Galderma Latest Developments
Table 94. Galderma Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Product Offered
Table 96. Bristol-Myers Squibb Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Product Offered
Table 101. Bayer Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Bayer Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Merz Pharma Product Offered
Table 106. Merz Pharma Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Merz Pharma Main Business
Table 108. Merz Pharma Latest Developments
Table 109. Merz Pharma Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Novartis Product Offered
Table 111. Novartis Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Novartis Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Valeant Product Offered
Table 116. Valeant Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Valeant Main Business
Table 118. Valeant Latest Developments
Table 119. Valeant Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Product Offered
Table 121. Pfizer Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Pfizer Basic Information, Company Total Revenue (in $ million), Dermatology Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. GlaxoSmithKline Product Offered
Table 126. GlaxoSmithKline Dermatology Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. GlaxoSmithKline Main Business
Table 128. GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Dermatology Drug
Figure 2. Dermatology Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Dermatology Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Dermatology Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of External Use
Figure 7. Product Picture of Oral
Figure 8. Product Picture of Injection
Figure 9. Global Dermatology Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Dermatology Drug Value Market Share by Type (2015-2020)
Figure 11. Dermatology Drug Consumed in Psoriasis
Figure 12. Global Dermatology Drug Market: Psoriasis (2015-2020) (K Units)
Figure 13. Global Dermatology Drug Market: Psoriasis (2015-2020) ($ Millions)
Figure 14. Dermatology Drug Consumed in Skin Infections
Figure 15. Global Dermatology Drug Market: Skin Infections (2015-2020) (K Units)
Figure 16. Global Dermatology Drug Market: Skin Infections (2015-2020) ($ Millions)
Figure 17. Dermatology Drug Consumed in Acne
Figure 18. Global Dermatology Drug Market: Acne (2015-2020) (K Units)
Figure 19. Global Dermatology Drug Market: Acne (2015-2020) ($ Millions)
Figure 20. Dermatology Drug Consumed in Dermatitis
Figure 21. Global Dermatology Drug Market: Dermatitis (2015-2020) (K Units)
Figure 22. Global Dermatology Drug Market: Dermatitis (2015-2020) ($ Millions)
Figure 23. Dermatology Drug Consumed in Other
Figure 24. Global Dermatology Drug Market: Other (2015-2020) (K Units)
Figure 25. Global Dermatology Drug Market: Other (2015-2020) ($ Millions)
Figure 26. Global Dermatology Drug Consumption Market Share by Application (2015-2020)
Figure 27. Global Dermatology Drug Value Market Share by Application (2015-2020)
Figure 28. Global Dermatology Drug Sales Market Share by Company in 2017
Figure 29. Global Dermatology Drug Sales Market Share by Company in 2019
Figure 30. Global Dermatology Drug Revenue Market Share by Company in 2017
Figure 31. Global Dermatology Drug Revenue Market Share by Company in 2019
Figure 32. Global Dermatology Drug Sale Price by Company in 2019
Figure 33. Global Dermatology Drug Consumption Market Share by Regions 2015-2020
Figure 34. Global Dermatology Drug Value Market Share by Regions 2015-2020
Figure 35. Americas Dermatology Drug Consumption 2015-2020 (K Units)
Figure 36. Americas Dermatology Drug Value 2015-2020 ($ Millions)
Figure 37. APAC Dermatology Drug Consumption 2015-2020 (K Units)
Figure 38. APAC Dermatology Drug Value 2015-2020 ($ Millions)
Figure 39. Europe Dermatology Drug Consumption 2015-2020 (K Units)
Figure 40. Europe Dermatology Drug Value 2015-2020 ($ Millions)
Figure 41. Middle East & Africa Dermatology Drug Consumption 2015-2020 (K Units)
Figure 42. Middle East & Africa Dermatology Drug Value 2015-2020 ($ Millions)
Figure 43. Americas Dermatology Drug Consumption Market Share by Countries in 2019
Figure 44. Americas Dermatology Drug Value Market Share by Countries in 2019
Figure 45. Americas Dermatology Drug Consumption Market Share by Type in 2019
Figure 46. Americas Dermatology Drug Consumption Market Share by Application in 2019
Figure 47. United States Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 48. United States Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 49. Canada Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 50. Canada Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 51. Mexico Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 52. Mexico Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 53. APAC Dermatology Drug Consumption Market Share by Countries in 2019
Figure 54. APAC Dermatology Drug Value Market Share by Regions in 2019
Figure 55. APAC Dermatology Drug Consumption Market Share by Type in 2019
Figure 56. APAC Dermatology Drug Consumption Market Share by Application in 2019
Figure 57. China Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 58. China Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 59. Japan Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 60. Japan Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 61. Korea Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 62. Korea Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 63. Southeast Asia Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 64. Southeast Asia Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 65. India Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 66. India Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 67. Australia Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 68. Australia Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 69. Europe Dermatology Drug Consumption Market Share by Countries in 2019
Figure 70. Europe Dermatology Drug Value Market Share by Countries in 2019
Figure 71. Europe Dermatology Drug Consumption Market Share by Type in 2019
Figure 72. Europe Dermatology Drug Consumption Market Share by Application in 2019
Figure 73. Germany Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 74. Germany Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 75. France Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 76. France Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 77. UK Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 78. UK Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 79. Italy Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 80. Italy Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 81. Russia Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 82. Russia Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 83. Middle East & Africa Dermatology Drug Consumption Market Share by Countries in 2019
Figure 84. Middle East & Africa Dermatology Drug Value Market Share by Countries in 2019
Figure 85. Middle East & Africa Dermatology Drug Consumption Market Share by Type in 2019
Figure 86. Middle East & Africa Dermatology Drug Consumption Market Share by Application in 2019
Figure 87. Egypt Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 88. Egypt Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 89. South Africa Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 90. South Africa Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 91. Israel Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 92. Israel Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 93. Turkey Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 94. Turkey Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 95. GCC Countries Dermatology Drug Consumption Growth 2015-2020 (K Units)
Figure 96. GCC Countries Dermatology Drug Value Growth 2015-2020 ($ Millions)
Figure 97. Global Dermatology Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 98. Global Dermatology Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 99. Americas Dermatology Drug Consumption 2021-2025 (K Units)
Figure 100. Americas Dermatology Drug Value 2021-2025 ($ Millions)
Figure 101. APAC Dermatology Drug Consumption 2021-2025 (K Units)
Figure 102. APAC Dermatology Drug Value 2021-2025 ($ Millions)
Figure 103. Europe Dermatology Drug Consumption 2021-2025 (K Units)
Figure 104. Europe Dermatology Drug Value 2021-2025 ($ Millions)
Figure 105. Middle East & Africa Dermatology Drug Consumption 2021-2025 (K Units)
Figure 106. Middle East & Africa Dermatology Drug Value 2021-2025 ($ Millions)
Figure 107. United States Dermatology Drug Consumption 2021-2025 (K Units)
Figure 108. United States Dermatology Drug Value 2021-2025 ($ Millions)
Figure 109. Canada Dermatology Drug Consumption 2021-2025 (K Units)
Figure 110. Canada Dermatology Drug Value 2021-2025 ($ Millions)
Figure 111. Mexico Dermatology Drug Consumption 2021-2025 (K Units)
Figure 112. Mexico Dermatology Drug Value 2021-2025 ($ Millions)
Figure 113. Brazil Dermatology Drug Consumption 2021-2025 (K Units)
Figure 114. Brazil Dermatology Drug Value 2021-2025 ($ Millions)
Figure 115. China Dermatology Drug Consumption 2021-2025 (K Units)
Figure 116. China Dermatology Drug Value 2021-2025 ($ Millions)
Figure 117. Japan Dermatology Drug Consumption 2021-2025 (K Units)
Figure 118. Japan Dermatology Drug Value 2021-2025 ($ Millions)
Figure 119. Korea Dermatology Drug Consumption 2021-2025 (K Units)
Figure 120. Korea Dermatology Drug Value 2021-2025 ($ Millions)
Figure 121. Southeast Asia Dermatology Drug Consumption 2021-2025 (K Units)
Figure 122. Southeast Asia Dermatology Drug Value 2021-2025 ($ Millions)
Figure 123. India Dermatology Drug Consumption 2021-2025 (K Units)
Figure 124. India Dermatology Drug Value 2021-2025 ($ Millions)
Figure 125. Australia Dermatology Drug Consumption 2021-2025 (K Units)
Figure 126. Australia Dermatology Drug Value 2021-2025 ($ Millions)
Figure 127. Germany Dermatology Drug Consumption 2021-2025 (K Units)
Figure 128. Germany Dermatology Drug Value 2021-2025 ($ Millions)
Figure 129. France Dermatology Drug Consumption 2021-2025 (K Units)
Figure 130. France Dermatology Drug Value 2021-2025 ($ Millions)
Figure 131. UK Dermatology Drug Consumption 2021-2025 (K Units)
Figure 132. UK Dermatology Drug Value 2021-2025 ($ Millions)
Figure 133. Italy Dermatology Drug Consumption 2021-2025 (K Units)
Figure 134. Italy Dermatology Drug Value 2021-2025 ($ Millions)
Figure 135. Russia Dermatology Drug Consumption 2021-2025 (K Units)
Figure 136. Russia Dermatology Drug Value 2021-2025 ($ Millions)
Figure 137. Spain Dermatology Drug Consumption 2021-2025 (K Units)
Figure 138. Spain Dermatology Drug Value 2021-2025 ($ Millions)
Figure 139. Egypt Dermatology Drug Consumption 2021-2025 (K Units)
Figure 140. Egypt Dermatology Drug Value 2021-2025 ($ Millions)
Figure 141. South Africa Dermatology Drug Consumption 2021-2025 (K Units)
Figure 142. South Africa Dermatology Drug Value 2021-2025 ($ Millions)
Figure 143. Israel Dermatology Drug Consumption 2021-2025 (K Units)
Figure 144. Israel Dermatology Drug Value 2021-2025 ($ Millions)
Figure 145. Turkey Dermatology Drug Consumption 2021-2025 (K Units)
Figure 146. Turkey Dermatology Drug Value 2021-2025 ($ Millions)
Figure 147. GCC Countries Dermatology Drug Consumption 2021-2025 (K Units)
Figure 148. GCC Countries Dermatology Drug Value 2021-2025 ($ Millions)
Figure 149. AbbVie Dermatology Drug Market Share (2018-2020)
Figure 150. LEO Pharma Dermatology Drug Market Share (2018-2020)
Figure 151. Johnson & Johnson Dermatology Drug Market Share (2018-2020)
Figure 152. Galderma Dermatology Drug Market Share (2018-2020)
Figure 153. Bristol-Myers Squibb Dermatology Drug Market Share (2018-2020)
Figure 154. Bayer Dermatology Drug Market Share (2018-2020)
Figure 155. Merz Pharma Dermatology Drug Market Share (2018-2020)
Figure 156. Novartis Dermatology Drug Market Share (2018-2020)
Figure 157. Valeant Dermatology Drug Market Share (2018-2020)
Figure 158. Pfizer Dermatology Drug Market Share (2018-2020)
Figure 159. GlaxoSmithKline Dermatology Drug Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets